3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
115
Squamous Cell Carcinoma of Head and Neck
61
Triple Negative Breast Neoplasms
57
Melanoma
54
Neoplasm Metastasis
50
Lung Neoplasms
50
Breast Neoplasms
41
Neoplasms
37
Colorectal Neoplasms
36
Carcinoma, Renal Cell
26
Head and Neck Neoplasms
25
Endometrial Neoplasms
25
Stomach Neoplasms
22
Uterine Cervical Neoplasms
21
Ovarian Neoplasms
21
Carcinoma, Transitional Cell
21
Urinary Bladder Neoplasms
20
Parkinson Disease 4, Autosomal Dominant Lewy Body
18
Esophageal Neoplasms
16
Recurrence
15
Pancreatic Neoplasms
14
Carcinoma, Hepatocellular
14
Sarcoma
12
Carcinoma, Squamous Cell
12
Carcinoma
12
Glioblastoma
11
Esophageal Squamous Cell Carcinoma
11
Prostatic Neoplasms
10
Brain Neoplasms
10
Carcinoma, Merkel Cell
9
Interventions
pembrolizumab
1
folfirinox
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Localized Pancreatic Adenocarcinoma
×
pembrolizumab
×
Clear all
NCT06384560
2026-02-13
PREOPANC-5
Amsterdam UMC, location VUmc
Phase 1/2
Recruiting
66 enrolled